Clinical trial
A Phase I Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
NCT03355794 is registered in ClinicalTrials.gov with Children's Hospital Medical Center, Cincinnati as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
- Lead sponsor
- Children's Hospital Medical Center, Cincinnati
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 14, 2017
- Completion date
- July 31, 2022
- Enrollment
- 19 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
anaplastic astrocytoma, bithalamic high grade glioma, brainstem glioma, diffuse intrinsic pontine glioma, glioblastoma, high grade glioma, malignant glioma of brain